As of December 2024 Glenmark Pharmaceuticals has a market cap of A$8.20 Billion. This makes Glenmark Pharmaceuticals the world's 2647th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.